Medical devices, healthcare technology and the business of care
510(k) clearance · K252344

BD Vacutainer Serum Blood Collection Tubes; BD Vacutainer Rapid Serum Tubes (RST)

Becton Dickinson and Company · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK252344

What did the FDA decide?

FDA's 510(k) database records K252344 for BD Vacutainer® Serum Blood Collection Tubes and BD Vacutainer® Rapid Serum Tubes (RST), filed by Becton, Dickinson and Company of Franklin Lakes, New Jersey. The device falls under classification name Tubes, Vials, Systems, Serum Separators, Blood Collection, regulation 21 CFR 862.1675, product code JKA, in the Clinical Chemistry specialty and review panel. The record lists a Traditional submission, received 07/28/2025, not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.

On 10/16/2026 FDA recorded the decision as Substantially Equivalent (SESE), which is 510(k) clearance rather than premarket approval. The record does not identify which tube configurations, components or modifications were the subject of the submission, and no summary statement is present in the supplied data. The clinical basis for the equivalence determination, any performance data, and the specific indications are not available here and would need the underlying FDA documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Clinical Chemistry
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K252344
Regulatory pathway
510(k) premarket notification
Product code
JKA
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tubes, Vials, Systems, Serum Separators, Blood Collection.

Product code
JKA
FDA device class
2

FDA decision timeline

  1. K252344 received

    Application receipt date recorded by FDA.

  2. K252344 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JKA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Becton Dickinson and Company

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Franklin Lakes, NJ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records